Twist Bioscience Corporation Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2024
For the fourth quarter, the company expects total revenue in the range of $77 million to $80 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.59 USD | -0.89% | +10.95% | +27.54% |
03/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
03/05 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
1st Jan change | Capi. | |
---|---|---|
+27.54% | 273.72Cr | |
-3.05% | 9.04TCr | |
+3.68% | 4.14TCr | |
-10.90% | 3.36TCr | |
+60.01% | 2.57TCr | |
-19.56% | 1.47TCr | |
-9.06% | 1.28TCr | |
-11.34% | 1.17TCr | |
-43.53% | 1.14TCr | |
+4.57% | 879.22Cr |